Drugs@FDA document

VOLTAREN-XR Letter · NDA 020254 SUPPL-20

Drugs@FDA document · NOVARTIS · Feb 28, 2011

Key facts

Drug name VOLTAREN-XR
Document type Letter
Application NDA020254
Submission SUPPL-20
Company NOVARTIS
Document date Feb 28, 2011
FDA document accessdata.fda.gov

At a glance

  • Labeling Document categories
  • 10–99 Documents for this application
  • None USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents